Pezzolo, Elena, et al. “Efficacy and Safety of Abrocitinib for Moderate-to-Severe Atopic Dermatitis in Adults: A 52-Week Real-World Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)”. Acta Dermato-Venereologica, vol. 106, Apr. 2026, pp. adv-2025, doi:10.2340/actadv.v106.adv-2025-0193.